stronger warnings about serious arrhythmias when using droperidol (Inapsine)

January 2002

The FDA is requiring stronger warnings about serious arrhythmias when using droperidol (Inapsine).

Droperidol is still commonly used for post-op N/V.

But droperidol can prolong the QT interval...and can lead to torsades de pointes and sudden death.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote